Back to Search
Start Over
A tick cell line as a powerful tool to screen the antimicrobial susceptibility of the tick-borne pathogen Anaplasma marginale.
- Source :
-
Experimental parasitology [Exp Parasitol] 2020 Oct; Vol. 217, pp. 107958. Date of Electronic Publication: 2020 Jul 27. - Publication Year :
- 2020
-
Abstract
- Anaplasma marginale is the causative agent of the severe bovine anaplasmosis. The tick Rhipicephalus microplus is one of the main vectors of A. marginale in tropical and subtropical regions of the world. After the tick bite, the bacterium invades and proliferates within the bovine erythrocytes leading to anemia, impairment of milk production and weight loss. In addition, infection can cause abortion and high mortality in areas of enzootic instability. Immunization with live and inactivated vaccines are employed to control acute bovine anaplasmosis. However, they do not prevent persistent infection. Consequently, infected animals, even if immunized, are still reservoirs of the bacterium and contribute to its dissemination. Antimicrobials are largely employed for the prophylaxis of bovine anaplasmosis. However, they are often used in sublethal doses which may select pre-existing resistant bacteria and induce genetic or phenotypic variations. Therefore, we propose a new standardized in vitro assay to evaluate the susceptibility of A. marginale strains to different antimicrobials. This tool will help health professionals to choose the more adequate treatment for each herd which will prevent the selection and spread of resistant strains. For that, we initially evaluated the antimicrobial susceptibility of two field isolates of A. marginale (Jaboticabal and Palmeira) infecting bovines. The least susceptible strain (Jaboticabal) was used for the standardization of an antimicrobial assay using a culture of Ixodes scapularis-derived tick cell line, ISE6. Results showed that enrofloxacin (ENRO) at 0.25, 1 or 4 μg/mL and oxytetracycline (OTC) at 4 or 16 μg/mL are the most efficient treatments, followed by OTC at 1 μg/mL and imidocarb dipropionate (IMD) at 1 or 4 μg/mL. In addition, this proposed tool has technical advantages compared to the previously established bovine erythrocyte culture. Thereby, it may be used to guide cattle farmers to the correct use of antimicrobials. The choice of the most suitable antimicrobial is essential to eliminate persistent infections, prevent the spread of resistant strains and help controlling of bovine anaplasmosis.<br /> (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Subjects :
- Anaplasmosis drug therapy
Anaplasmosis microbiology
Animals
Anti-Bacterial Agents therapeutic use
Arachnid Vectors parasitology
Brazil
Cattle
Cattle Diseases drug therapy
Cattle Diseases microbiology
Cell Line
Enrofloxacin pharmacology
Erythrocytes microbiology
Imidocarb analogs & derivatives
Imidocarb pharmacology
Imidocarb therapeutic use
Male
Microbial Sensitivity Tests
Oxytetracycline pharmacology
Oxytetracycline therapeutic use
Real-Time Polymerase Chain Reaction
Rhipicephalus parasitology
Anaplasma marginale drug effects
Anaplasmosis prevention & control
Anti-Bacterial Agents pharmacology
Arachnid Vectors cytology
Cattle Diseases prevention & control
Rhipicephalus cytology
Subjects
Details
- Language :
- English
- ISSN :
- 1090-2449
- Volume :
- 217
- Database :
- MEDLINE
- Journal :
- Experimental parasitology
- Publication Type :
- Academic Journal
- Accession number :
- 32730769
- Full Text :
- https://doi.org/10.1016/j.exppara.2020.107958